Superficial wound swabbing: A novel method of sampling and processing wound fluid for subsequent immunoassay analysis in diabetic foot ulcerations

Diabetes Care

Volumn 35, Issue 11, 2012, Pages 2113-2120

  Schmohl, Michael ^a   Beckert, Stefan ^a   Joos, Thomas O ^a   Königsrainer, Alfred ^a   Schneiderhan Marra, Nicole ^a   Löffler, Markus W ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE A; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; MATRILYSIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTROPHIL COLLAGENASE; STROMELYSIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; ASPIRATION; CONTROLLED STUDY; DIABETIC FOOT; FEMALE; FOOT ULCER; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; SAMPLING; SUPERFICIAL WOUND SWABBING; WOUND FLUID;

DIABETIC FOOT; FEMALE; FOOT ULCER; HUMANS; IMMUNOASSAY; INTERLEUKIN-17; INTERLEUKIN-4; INTERLEUKIN-8; MALE; SPECIMEN HANDLING; THYMUS GLAND;

EID: 84868123837     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-2547     Document Type: Article

References (32)

1. Eming SA, Krieg T, Davidson JM. Inflammation inwound repair: molecular and cellular mechanisms. J Invest Dermatol 2007;127:514-525
2. Jeandrot A, Richard JL, Combescure C, et al. Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study. Diabetologia 2008;51:347-352
3. Weigelt C, Rose B, Poschen U, et al. Immune mediators in patients with acute diabetic foot syndrome. Diabetes Care 2009;32:1491-1496
4. Gohel MS, Windhaber RA, Tarlton JF, Whyman MR, Poskitt KR. The relationship between cytokine concentrations and wound healing in chronic venous ulceration. J Vasc Surg 2008;48:1272-1277
5. Schmidtchen A. Degradation of antiproteinases, complement and fibronectin in chronic leg ulcers. Acta Derm Venereol 2000;80:179-184
6. Trengove NJ, Bielefeldt-Ohmann H, Stacey MC. Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers. Wound Repair Regen 2000;8:13-25 (Pubitemid 30140796)
7. Trengove NJ, Stacey MC, MacAuley S, et al. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen 1999;7:442-452 (Pubitemid 30027566)
8. Wallace HJ, Stacey MC. Levels of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in chronic venous leg ulcers - correlations to healing status. J Invest Dermatol 1998;110:292-296 (Pubitemid 28144608)
9. Wysocki AB, Grinnell F. Fibronectin profiles in normal and chronic wound fluid. Lab Invest 1990;63:825-831
10. Yager DR, Zhang LY, Liang HX, Diegelmann RF, Cohen IK. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J Invest Dermatol 1996;107:743-748 (Pubitemid 26371092)
11. Fivenson DP, Faria DT, Nickoloff BJ, et al. Chemokine and inflammatory cytokine changes during chronic wound healing. Wound Repair Regen 1997;5:310-322 (Pubitemid 127689592)
12. Liu Y, Min D, Bolton T, et al. Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers. Diabetes Care 2009;32:117-119
13. Wiegand C, Schönfelder U, Abel M, Ruth P, Kaatz M, Hipler UC. Protease and proinflammatory cytokine concentrations are elevated in chronic compared to acute wounds and can be modulated by collagen type I in vitro. Arch Dermatol Res 2010;302:419-428
14. Acosta JB, del Barco DG, Vera DC, et al. The pro-inflammatory environment in recalcitrant diabetic foot wounds. Int Wound J 2008;5:530-539
15. Yager DR, Kulina RA, Gilman LA. Wound fluids: a window into the wound environment? Int J Low Extrem Wounds 2007;6:262-272 (Pubitemid 350131921)
16. Chen SM, Ward SI, Olutoye OO, Diegelmann RF, Kelman Cohen I. Ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitors. Wound Repair Regen 1997;5:23-32 (Pubitemid 127686717)
17. James TJ, Hughes MA, Cherry GW, Taylor RP. Simple biochemical markers to assess chronic wounds. Wound Repair Regen 2000;8:264-269
18. Wysocki AB, Kusakabe AO, Chang S, Tuan TL. Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase-B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing. Wound Repair Regen 1999;7:154-165 (Pubitemid 29331919)
19. Coerper S, Wicke C, Pfeffer F, Köveker G, Becker HD. Documentation of 7051 chronic wounds using a new computerized system within a network of wound care centers. Arch Surg 2004;139:251-258 (Pubitemid 38282664)
20. Wound infection in clinical practice. An international consensus. Int Wound J 2008; 5(Suppl. 3):iii-11
21. European Medicines Agency. Guideline on Validation of Bioanalytical Methods. European Medicines Agency, London, United Kingdom, 2010, p. 17
22. Trengove NJ, Langton SR, Stacey MC. Biochemical analysis of wound fluid from nonhealing and healing chronic leg ulcers. Wound Repair Regen 1996;4:234-239 (Pubitemid 126674092)
23. Zillmer R, Trøstrup H, Karlsmark T, Ifversen P, Agren MS. Duration of wound fluid secretion from chronic venous leg ulcers is critical for interleukin-1α, interleukin-1β, interleukin-8 levels and fibroblast activation. Arch Dermatol Res 2011;303:601-606
24. Chow LW, Loo WT, Yuen KY, Cheng C. The study of cytokine dynamics at the operation site after mastectomy. Wound Repair Regen 2003;11:326-330 (Pubitemid 37122563)
25. Grimstad O, Sandanger O, Ryan L, et al. Cellular sources and inducers of cytokines present in acute wound fluid. Wound Repair Regen 2011;19:337-347
26. Hoffman R, Noble J, Eagle M. The use of proteases as prognostic markers for the healing of venous leg ulcers. J Wound Care 1999;8:273-276
27. Ono I, Gunji H, Suda K, Iwatsuki K, Kaneko F. Evaluation of cytokines in donor site wound fluids. Scand J Plast Reconstr Surg Hand Surg 1994;28:269-273
28. Barone EJ, Yager DR, Pozez AL, et al. Interleukin-1alpha and collagenase activity are elevated in chronic wounds. Plast Reconstr Surg 1998;102:1023-1027; discussion 1028-1029
29. Wysocki AB, Staiano-Coico L, Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 1993;101:64-68 (Pubitemid 23213014)
30. Löffler M, Zieker D, Weinreich J, et al. Wound fluid lactate concentration: a helpful marker for diagnosing soft-tissue infection in diabetic foot ulcers? Preliminary findings. Diabet Med 2011;28:175-178
31. Muller M, Trocme C, Lardy B, Morel F, Halimi S, Benhamou PY. Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is a predictor of wound healing. Diabet Med 2008;25:419-426 (Pubitemid 351490124)
32. Bank U, Ansorge S. More than destructive: neutrophil-derived serine proteases in cytokine bioactivity control. J Leukoc Biol 2001;69:197-206 (Pubitemid 32163431)